LMP-1 ve Nazofaringial Karsinoma

Cilt: 39 Sayı: 3 22 Temmuz 2014
Anggun İndah Budiningrum , Achmad Rofi'i , Suharjono Suharjono , Fatchiyah Fatchiyah
PDF İndir
EN TR

LMP-1 and Nasopharyngeal Carcinoma (NPC)

Abstract

Purpose: This study aims to determine the interaction of LMP-1 with H2O2 , nitrosamine, and nicotine to predict the external factor that affected LMP-1, which activates lytic phase on nasopharyngeal carcinoma (NPC). Materials and Methods: The amino acid sequence of human LMP1 (GI: 343177335) and compound structure of H2O2 (ID:784), nicotine (ID: 89594), and nitrosamine (ID: 37183) was obtained from database The National center of Biotechnology Information. The 3-dimension modeling structure of LMP-1 predicted using SWISS-MODEL web server. Hex 6.12 was used for the purpose of docking of the lead with the target molecule. Ligand details interaction then detected by LigPlus+ v.1.4.4 software. Molecular graphics and analysis were performed with PyMOL. Results: LMP-1 has interaction with H2O2 , nitrosamine, and nicotine. Total energy that use of LMP-1 to interaction with H2O2 (-67,79 kJ/mol) is lowest than interaction with nicotine (-149,43 kJ/mol) and nitrosamine (-82,93 kJ/mol). The kind of interaction between LMP-1 and H2O2 is hydrogen bond whereas interaction of LMP-1 between nicotine and nitrosamine are hydrophobic bond. Conclusions:LMP-1 has strongest interaction with H2O2 than nicotine and nitrosamine. This is predicted that H2O2 is external factor that affect LMP-1 switching to lytic infection in NPC patients.

Keywords

H2O2, LMP-1; nasopharyngeal carcinoma, nicotine, nitrosamine

Kaynakça

  1. Cho WC. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Molecular Cancer. 2007;6:1-9.
  2. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5: 423-8.
  3. Yoshizaki T, Kondo S, Wakisaka N, Murono S, Endo K, Sugimoto H, Nakanishi S, Tsuji A, Ito M. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Cancer Letters. 2013;337:1-7.
  4. Young LS & Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757–68.
  5. Du CW, Wen BG, Li DR, Lin YC, Zheng YW, Chen L, Chen JY, Lin W, Wu MY.Latent membrane protein-1 of Epstein-Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell. Exp Oncol. 2005;27:267-72.
  6. Budiningrum AI, Rofi’i A, Suharjono S, Fatchiyah F. PARP-1 expression against Epstein-Barr virus LMP-1 and BZLF-1 in undifferentiated nasopharyngeal carcinoma. J Exp Integr Med. 2013;3:299-304.
  7. Lassoued S, Gargouri B, El Feki Ael F, Attia H, van Pelt J. Transcription of the Epstein-Barr Virus lytic cycle activator BZLF-1 during oxidative stress induction. Biol Trace Elem Res. 2010;137:13-22.
  8. Rofi’i A, Fatchiyah F, Rahayu P, Muhyi R, Sumitro SB. Reactive oxygen species, NFᴋB, and p53 levels in tissue of undifferentiated nasopharyngeal carcinoma. Oxid Antioxid Med Sci. 2013;2:143-7.
  9. Dood LE, Sengupta S, Chen I-H, den Bonn JA, Cheng Y-J, Westra W, Newton MA, Mittl BF, McShane L, Chen C-J, Ahlquist P, Hildesheim A. Genes involved in DNA repair and nitrosamine metabolism and those located on chromosome 14q32 are dysregulated in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2006;15:2216-25.
  10. Yu MC & Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-9.

Kaynak Göster

MLA
Budiningrum, Anggun İndah, vd. “LMP-1 ve Nazofaringial Karsinoma”. Cukurova Medical Journal, c. 39, sy 3, Eylül 2014, ss. 480-7, doi:10.17826/cutf.53492.